Notice of Cancellation of the June 18, 2024 Application Receipt Date for RFA-EY-23-001 "BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)"
Notice NOT-EY-24-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2024 Category: Research Source Type: funding
Notice of Change to NHGRI-specific language in RFA-HG-23-018, Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)
Notice NOT-HG-24-032 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2024 Category: Research Source Type: funding
Notice of Legislative Mandates in Effect for FY 2024
Notice NOT-OD-24-110 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2024 Category: Research Source Type: funding
Notice to change the expiration date of PAR-21-255: Investigator Initiated Research in Computational genomics and Data Science (R21 Clinical Trial Not Allowed)
Notice NOT-HG-24-034 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2024 Category: Research Source Type: funding
Notice to change the expiration date of PAR-21-254: Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
Notice NOT-HG-24-033 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 30, 2024 Category: Research Source Type: funding
Diversity and Inclusion (D & I) Site Resource Grants Program
Seed funding to improve the reach of clinical research into underrepresented communities. Applications from rural and tribal research sites are encouraged. Geographic coverage: Nationwide -- Association of Clinical Research Organizations (ACRO) (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - April 29, 2024 Category: American Health Source Type: funding
Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)
Funding Opportunity RFA-MH-25-185 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Proj...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 29, 2024 Category: Research Source Type: funding
Notice of Special Interest (NOSI) on Catalyzing Research and Training on the Impact of HIV on the Health Across the Lifespan of Women Living with HIV Through Administrative Supplements to Existing Fogarty International Centers HIV Programs
Notice NOT-TW-24-005 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 29, 2024 Category: Research Source Type: funding
Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)
Funding Opportunity RFA-MH-25-186 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Proj...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 29, 2024 Category: Research Source Type: funding
Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-25-005 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the Type 1 Diabetes TrialNet Clinical Network Hub (HUB), a screening and clinical activities coordination unit for clinical trials focusing on the prevention of and early intervention in type 1 diabetes (T1D). The main objective of the HUB is to increase the efficiency and productivity of the TrialNet network by providing coordination of communications and outreach and developing new tools and approaches to increase screening, recruitment and retention. This N...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 29, 2024 Category: Research Source Type: funding
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-26-003 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Emerging Investigator Award (EIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The EIA is intended to support a research program, rather than a research project, by providing t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
Funding Opportunity RFA-HL-26-002 from the NIH Guide for Grants and Contracts. The purpose of the NHLBI Outstanding Investigator Award (OIA) is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PDs/PIs) who are currently PDs/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrates their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. The OIA is intended to support a research program, rather than a research project, by providin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding
NINDS Policy for applications requesting $500,000 or more in direct costs in any year (excluding consortium F and A)on NIH Parent R01 Notices of Funding Opportunities
Notice NOT-NS-24-079 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding
May 27 (Monday), 2024: NIH Closed for the Federal Holiday
NIH (including help desks) will be closed on Monday, May 27, 2024 for the federal holiday (Memorial Day). If a grant application due date falls on a federal holiday, the application deadline is automatically extended to the next business day. (Source: NIH Extramural Nexus)
Source: NIH Extramural Nexus - April 26, 2024 Category: Research Authors: NIH Staff Tags: Calendar General Source Type: funding
Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
Funding Opportunity RFA-DK-25-004 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to continue support for the TrialNet Coordinating Center (TNCC). The TrialNet network identifies people with type 1 diabetes (T1D) at stages before and after onset of clinical symptoms and enrolls them in trials and studies aimed at prevention of progression to clinical disease and preservation of insulin production. The TNCC participates in ongoing studies and intervention trials as well as the design and conduct of new studies and intervention trials. The TNCC will: (1) support a w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2024 Category: Research Source Type: funding
